Invivyd (IVVD) Free Cash Flow (2021 - 2025)
Invivyd (IVVD) posted Free Cash Flow of -$15.6 million for Q4 2025, down 89.78% on a QoQ basis from -$8.2 million in Q3 2025, and up 58.42% year-over-year from -$9.9 million in Q4 2024.
Invivyd (IVVD) Free Cash Flow (2021 - 2025) Analysis & Trends
Invivyd's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$15.6 million for Q4 2025.
- Quarterly Free Cash Flow rose 58.42% year-over-year to -$15.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$58.3 million (up 65.84% YoY) and the FY2025 annual result came in at -$58.3 million, up 65.84% from the prior year.
- Free Cash Flow was -$15.6 million for Q4 2025 at Invivyd, down from -$8.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$8.2 million in Q3 2025 and bottomed at -$76.5 million in Q4 2021.
- A 5-year average of -$40.6 million and a median of -$40.4 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 135.83% — and 2025, when it surged 79.2%.
- Invivyd's Free Cash Flow stood at -$76.5 million in 2021, then jumped by 31.81% to -$52.2 million in 2022, then decreased by 13.53% to -$59.2 million in 2023, then surged by 36.51% to -$37.6 million in 2024, then jumped by 58.42% to -$15.6 million in 2025.
- Business Quant data shows IVVD's Free Cash Flow at -$15.6 million in Q4 2025, -$8.2 million in Q3 2025, and -$13.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -15.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.64 Mn |
| Dec 31, 2025 | -15.64 Mn |
| Sep 30, 2025 | -8.24 Mn |
| Sep 30, 2025 | -8.24 Mn |
| Jun 30, 2025 | -13.29 Mn |
| Jun 30, 2025 | -13.29 Mn |
| Mar 31, 2025 | -21.12 Mn |
| Mar 31, 2025 | -21.12 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Sep 30, 2024 | -39.61 Mn |
| Sep 30, 2024 | -39.61 Mn |
| Jun 30, 2024 | -41.52 Mn |
| Jun 30, 2024 | -41.52 Mn |
| Mar 31, 2024 | -51.90 Mn |
| Mar 31, 2024 | -51.90 Mn |
| Dec 31, 2023 | -59.23 Mn |
| Dec 31, 2023 | -59.23 Mn |
| Sep 30, 2023 | -35.25 Mn |
| Sep 30, 2023 | -35.25 Mn |